SEC 2069 Potential persons who are to respond to the collections of
(11-01) information contained in this form are not required to respond
Previous unless the form displays a currently valid OMB control number.
versions
obsolete
-------------------------
OMB APPROVAL
-------------------------
OMB Number: 3235-0167
Expires: October 31, 2004
Estimated average burden
hours per response: 1.5
-------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g)
of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports
Under Sections 13 and 15(d) of the Securities Exchange Act of 1934
Commission File Number: 000-33217
---------
Genesis Health Ventures, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
101 East State Street
Kennett Square, Pennsylvania 19348
(610) 444-6350
------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Warrants to purchase Common Stock, par value $.02 per share,
exercisable until October 2, 2002(1) (2)
------------------------------------------------------------
(Title of each class of securities covered by this Form)
Common Stock, par value $.02 per share(2)
-----------------------------------------------------------
(Titles of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(i) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 15d-6 [ ]
Approximate number of holders of record as of the certification or notice
date: Zero
Pursuant to the requirements of the Securities Exchange Act of 1934, Genesis
Health Ventures, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
Genesis Health Ventures, Inc.
By: George V. Hager, Jr.
-------------------------------------
Name: George V. Hager, Jr.
Title: Executive Vice President and
Chief Financial Officer
Date: May 9, 2003
(1) On October 2, 2002, these warrants expired.
(2) A Registration Statement on Form 8-A was filed with the SEC on
October 2, 2001 related to these securities.
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant shall file three copies of Form 15, one of which shall be manually
signed. It may be signed by an officer of the registrant, by counsel or by any
other duly authorized person. The name and title of the person signing the form
shall be typed or printed under the signature.